Background
==========

Acute gastroenteritis (AGE) is a common cause for hospital/clinic visits and hospitalisations in children as well as adults \[[@B1],[@B2]\]. It is characterised by diarrhoea, vomiting and abdominal pain that may lead to hypovolemic shock and dehydration, and subsequently death in severe cases. Children in developing countries are particularly at risk of both morbidity and mortality \[[@B1]\]. Worldwide, gastroenteritis affects 3 to 5 billion children each year, and accounts for 1.5 to 2.5 million deaths per year or 12% of all deaths among children less than 5 years of age \[[@B1]\]. In developed countries AGE accounts for 300 deaths per year \[[@B1]\].

Among adults, an estimated 179 million cases of AGE occur each year, resulting in millions of clinic visits, nearly 500,000 hospitalisations, and \>5000 deaths \[[@B2]\]. Although the burden of AGE in children has been described extensively, there is little data on AGE in adults.

Four major viral pathogens have been associated with AGE. These include three RNA viruses (rotavirus, norovirus, and astrovirus) and one DNA virus (enteric adenovirus) \[[@B3],[@B4]\]. Saporovirus, Aichivirus and members of enterovirus group also cause AGE but are less common \[[@B5]\].

Noroviruses are now recognised as the leading cause of epidemic gastroenteritis in all age groups, accounting for over 90% of viral gastroenteritis outbreaks and approximately 50% of all gastroenteritis outbreaks \[[@B6]\]. Past reviews have shown that norovirus was responsible for 4.4%--8.7% of AGE cases among adults and elderly individuals admitted to the emergency department (ED) or hospitalized \[[@B7]\]. In Bangladesh, it is estimated that 200,000 deaths are caused by norovirus gastroenteritis annually though more data on viral aetiology in AGE in developing countries is sparse \[[@B8]\]. Rotavirus is the most common cause of severe childhood diarrhoea worldwide \[[@B9]\]. It has seven serogroups (A-G) that are classified on the basis of antigenic variations. Each year worldwide, rotavirus causes approximately 111 million episodes of gastroenteritis requiring only home care, 25 million office visits, and 2 million hospitalizations \[[@B10]\]. Enteric adenoviruses can also cause AGE. The prevalence rate of adenovirus gastroenteritis is not as high as rotavirus or norovirus infections, however it is still very important to monitor these infections for epidemiologic and surveillance studies. Enteric adenovirus have been related to AGE in variable frequency (ranging from 1.4 to 10%), depending on the geographic settings \[[@B11],[@B12]\]. Astrovirus has also been associated with AGE, with a frequency range between 2% to 26% \[[@B13]\]. However, there is a paucity of data on viral aetiology in AGE in the Middle East both in adult and in paediatric population. Indeed, in Qatar there has not been any study investigating viral aetiology of AGE to date.

This study prospectively enrolled and tested children and adults with AGE presenting to our hospital to determine the frequency and aetiology of viral infectious AGE, using real-time reverse transcription (RT)-PCR and primers for adenovirus, astrovirus, enterovirus, and rotavirus. To our knowledge, no study has reported complete information regarding the number and distribution of these four viruses responsible for gastroenteritis in hospitalised patients (children and adults) in Qatar specifically or in the Middle East in general.

Methods
=======

Patients
--------

Patients who visited the hospital at Hamad Medical Corporation (HMC), Qatar with AGE-like complaints were enrolled in the study; they were aged 1 month to 84 yr old. Demographic information and clinical history was collected for all the patients. A total of 288 patients were enrolled in the study. The patients were enrolled in the study between June 2009 and November 2009.

Patients who visited the hospital with complaints of AGE were enrolled in the study after excluding those with bloody and formed stools. AGE was defined as ≥1 episode diarrhoea with abdominal discomfort with 24 hour period and passing of loose/watery/soft stool.

All enrolled patients/their guardians, in case of children gave written informed consent. The study was approved by the ethical board at Hamad Medical Research Center.

Stool samples collection and pre-treatment
------------------------------------------

Stool samples were collected from each subject during the hospital visit within 24 hours. The samples were obtained only once from each patient. A total of 288 samples were collected (one sample per patient) and frozen at −86°C. The frozen samples were transported to Qatar University Health Science Department research laboratory for analysis.

One hundred milligram (100 mg) of solid or liquid stool was re-suspended in 900 μl Buffer ASL (Stool Lysis Buffer). Each sample was then vortexed vigorously for 1 minute. Samples were then incubated for 10 minutes at room temperature to allow sedimentation of large stool particles. Approximately 500 μl supernatant was transferred from the top of the suspension to a fresh screw cap tube without carryover of large stool particles. Finally, samples were incubated for 10 minutes at 70°C in a thermoshaker.

Extraction of viral RNA
-----------------------

Pre-treated samples were placed into an extraction instrument, The EZ1 Mini. The manufacturer's instructions were followed to extract viral RNA (QIAGEN QIAamp Viral RNA Mini Kits EZ1 Virus Mini Kit v2.0, catalog number 955134, Germany).

### Viruses

Amplification and detection of the four viruses (norovirus, adenovirus, rotavirus and astrovirus) was performed by a two tube multiplex PCR assay (Fast Track Diagnostics, Luxemburg) using an ABI 7500 Real Time PCR instrument, according to the manufacturer's instructions.

### Bacteria

A swab of each stool specimen was examined for bacteria, including *Salmonella spp., Shigella spp., E. coli spp,* and *Campylobacter spp* using routine diagnostic assays.

Statistical analysis
--------------------

Prevalence rates were expressed as percentages. No statistical analyses were performed for this study.

Results
=======

Patients
--------

During the study period, 288 subjects were enrolled. Patient demographics are summarised in Table [1](#T1){ref-type="table"}.

###### 

Patient characteristics

  **Characteristic**             **Value (n = 288)**
  ------------------------------ ---------------------
  Age, years                     16.6 (≤1 -84)
    Median (range)               38 (13.2%)
    \<1                          83 (29%)
    1-10                         29 (10.1%)
    11-20                        75 (26%)
    21-50                        24 (8.3%)
    51-60                        29 (10.1%)
    \>60                         10 (3.5%)
    Unspecified age               
  Gender                          
    Male                         153 (53.1%)
    Female                       129 (44.8%)
    Sex not recorded             6 (2.1%)
  Chronic diseases               Total = 27 (9.4%)
  Cardiovascular disease (CVD)   2
  Acute renal failure            1
  Renal disease                  8
  Anaemia                        11
  Lymphoma/Leukemia              2
  Liver disease                  2
  Irritable bowel syndrome       1

All the patients were Qatar residents at time of the study, though not all were Qatari nationals.

Aetiology from the stool samples
--------------------------------

All the subjects provided stool specimens. A total of 288 stool samples were analysed, and viral agents were identified in 131 patients (45.5%), followed by bacterial infections (n = 34; 12.2%).

Table [2](#T2){ref-type="table"} summarises the sample numbers which tested positive for virus types by month of study. The highest number of infections was detected in July and September (the warm season in Qatar).

###### 

Samples tested positive for viruses by month

       **Month**        **Viruses N (%)**                      
  -------------------- ------------------- ---------- -------- --------
     June (n = 37)          10 (27%)        8 (22%)    2 (5%)     0
     July (n = 99)          32 (32%)        11 (11%)   8 (8%)   1 (1%)
    August (n = 32)         15 (47%)         1 (3%)    1 (3%)     0
   September (n = 72)       16 (22%)        10 (14%)   5 (7%)     0
    October (n = 41)         9 (22%)           0       2 (5%)     0

\*Seven samples were excluded due to poor sample quality or due to not obtaining enough samples to analyse.

Overall, norovirus was detected in 28.5% of stool specimens (82 of 288); rotavirus was detected in 10.4% (30 of 288); adenovirus was detected in 6.25% (18 out of 288); and astrovirus was detected in 0.30% (1 out of 288). No patients were co-infected with more than one virus. Norovirus was the predominant viral agent identified in this study.

*Salmonella* was the most common bacterial species detected (n = 23), followed by *E. Coli* (n = 6); *Shigella* (n = 3); and *Campylobacter* (n = 3).

Epidemiologic features
----------------------

The distribution of patients according to age is shown in Table [3](#T3){ref-type="table"}.

###### 

Viral aetiology distribution by patient age

    **Age (yr)**     **Norovirus (N = 82)**   **Rotavirus (N = 30)**   **Adenovirus (N = 18)**   **Astrovirus (N = 1)**
  ----------------- ------------------------ ------------------------ ------------------------- ------------------------
         \<1               10 (12.2%)               11 (36.7%)                3 (16.7%)                    0
       N = 38                                                                                   
        1-10               17 (20.7%)               10 (33.3%)                8 (44.4%)                    0
       N = 83                                                                                   
        11-20              9 (11.0%)                    0                     2 (11.1%)                 1 (100%)
       N = 29                                                                                   
        21-50              29 (35.4%)               5 (16.7%)                 2 (11.1%)                    0
       N = 75                                                                                   
        51-60               7 (8.5%)                4 (13.3%)                     0                        0
       N = 24                                                                                   
        \>60               10 (12.2%)                   0                     3 (16.7%)                    0
       N = 29                                                                                   
   Unspecified age             0                        0                         0                        0
       N = 10                                                                                   
      **Total**        **82 (28.4**%**)**       **30 (10.4**%**)**          **18 (6.25)**          **1 (0.30**%**)**

Norovirus was the most commonly detected viral pathogen amongst all the age groups with an almost even distribution in all age groups. Rotavirus and adenovirus were more common in children under 5 yr. However, the numbers were too small to make definitive conclusions. Astrovirus was found in only one person.

Discussion
==========

This study provides novel data on the infectious causes of AGE in children and adults in Qatar. A viral agent was identified in almost 50% of the patients (131/288). No correlations of symptom severity and viral aetiology were made in this study. The causes of these diseases (e.g. recent travel, food, etc.) were not investigated. Although the highest rate of infection was observed in July and September, which constitute the warm season in Qatar, it is difficult to make accurate conclusions re seasonality due to the low number of the samples; the fact that the samples were tested only once during the 6 month study period and the differences could be explained by the higher number of subjects recruited during those two months (Table [2](#T2){ref-type="table"}).

Norovirus was the most frequently identified cause of hospital visits for AGE, with detection in 28.4% and an almost even distribution across all age groups. This correlates well with a study of AGE in adults by Bresee *et al.*, who also found norovirus to be the most common aetiologic agent for AGE (detected in 27% of patients with a median age of 31 yr) \[[@B2]\]. Furthermore, other studies on adults in industrialised countries have also identified norovirus as the leading cause of AGE -- infecting 30% of adults in England \[[@B14]-[@B16]\]. Noroviruses has been detected in 16% of cases and 3% of controls in outpatient clinics in Germany across all age groups \[[@B17]\]. However, other studies have found a prevalence ≤10% for norovirus in AGE \[[@B17]-[@B19]\]. The higher prevalence in our study may reflect a higher rate of infection with norovirus in Qatar though larger studies may be required to corroborate this finding.

Rotavirus was found in 10.4% of subjects, mostly children less than 5 years of age. This is consistent with previous studies which have shown that rotaviruses are the most common cause of severe gastroenteritis among young children, but adult cases are thought to be uncommon \[[@B20]-[@B22]\]. The nine cases of rotavirus infection in adults may reflect the lack of rotavirus children's immunisation programme in Qatar until very recently (March 2009). The vaccine is now offered to all children less than 2 years of age, therefore, many patients would not have been immunised when this study was undertaken. Rotavirus vaccine may also confer protection in parents of vaccinated children \[[@B23]\]. Thus, conducting such a study in the rotavirus vaccine era is a limitation in itself.

*Salmonella* and *E. Coli* species were the most common bacterial pathogens identified. However, antiobiotic use was not monitored in this study therefore it is difficult to comment on these findings.

This study has several limitations. This study did not take into account correlation of clinical symptoms or duration of illness with viral aetiology. Therefore, we cannot ascertain variables that would help clinicians target specific patients for testing. Furthermore, our samples were collected from June 2009 to November 2009, which are mostly the summer months in Qatar and many residents travel to various countries and may carry viruses back with them though no data had been collected to assess patients for recent international travel; therefore, the contribution of this factor to viral aetiology is not known. In addition, we investigated only one strain of adenovirus, astrovirus and rotavirus; and two strains of norovirus. All common strains of these viruses should be investigated in future studies. Moreover, only patients presenting to a hospital were included in this study. In order to investigate the true burden of viral gastroenteritis, community-based studies are necessary. Finally, the lack of healthy controls limits conclusions about the relative importance of each pathogen. Despite these limitations, this study provides the most comprehensive data to date on the aetiology of AGE in patients in Qatar.

This study indicated that the two most common gastroenteritis viruses in Qatar are the norovirus and rotavirus. Nevertheless, large scale controlled studies are necessary to fully understand the aetiology and burden of viral pathogens in AGE in Qatar. Future studies should be carried out in samples collected throughout the year to assess the impact of winter vs. summer infections and international travel. Correlations of viruses with clinical symptoms and symptom severity also need to be performed.

Conclusion
==========

The epidemiologic surveillance of enteric viruses is a key step in understanding the burden of these infections in human health and their impact on the national health costs in Qatar. To date, no data on viral epidemiologic surveillance of AGE have been published in Qatar. The high prevalence of viral agents found in this study may have important implications for testing patients with AGE and minimizing use of antibiotics. The aim of control and prevention plans for viral gastroenteritis is to minimise nosocomial infections, to limit unnecessary antibiotic treatment, and ultimately to help develop a vaccination/immunisation campaign at the national level, if necessary, which are all significant improvements to the health system needed in Qatar.
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